Medical/Pharmaceuticals
Insilico Medicine and University of Cambridge Announce a Collaboration on Target Identification for Human Diseases Linked to Protein Liquid-liquid Phase Separation
HONG KONG, Sept. 7, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end artificial intelligence (AI) -driven drug discovery company, specialized in target discovery, small molecule chemistry, and clinical development, announced a collaboration with theUniversity of Cambridge. The agreement out...
2021-09-07 18:15
3678
Ethics Approval Granted for Clinical Trial of World's First Nasal Swab Designed Specifically for Children
* Rhinomed has created the world's first nasal swab designed specifically for children — The Rhinoswab Junior™ * Ethics approval has been received for a clinical trial to commence with the Murdoch Children's Research Institute (MCRI) at The Royal Children's Hospital in Melbourne * Trial seek...
2021-09-07 18:00
3005
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021
- Two new analyses of Movantik® (naloxegol) data evaluated the safety and efficacy of Movantik in a subgroup of patients aged ≥ 65 years - Analysis of Movantik effects on rapid and sustained improvement of both spontaneous and complete spontaneous bowel movements in the Movantik group vs. placeb...
2021-09-07 18:00
4597
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer
BENGALURU, India, Sept. 7, 2021 /PRNewswire/ -- Today, Jubilant Biosys Limited
announced the appointment ofGiuliano Perfetti as its Chief Executive Officer.
2021-09-07 16:11
6245
MIM Software Inc. Announces AI Segmentation and Single Timepoint Dosimetry Capabilities for Molecular Radiotherapy
CLEVELAND, Sept. 7, 2021 /PRNewswire/ -- MIM Software Inc., a leading global provider of medical imaging software, announced today new innovations to MIM SurePlan™ MRT, its software package for Molecular Radiotherapy. MIM SurePlan MRT has received CE Mark approval for new artificial intelligence...
2021-09-07 15:00
4207
NeuExcell Therapeutics and Spark Therapeutics Announce Research Collaboration Agreement to Develop a Novel Gene Therapy for Huntington's Disease
-- Using NeuExcell's neuroregenerative gene therapy platform, the collaboration aims to develop an effective and safe treatment for patients suffering from Huntington's Disease. -- Spark Therapeutics' excellence in R&D and proprietary adeno-associated virus (AAV) vector gene therapy platform ma...
2021-09-07 12:00
4500
Major new study reveals that half of all people fear the internet and smartphones are damaging wellbeing
DHAHRAN, Saudi Arabia, Sept. 7, 2021 /PRNewswire/ -- As the world adjusts to a
post-pandemic reality dominated by technology, public concerns about the
dangers of over-consumption are gathering pace. According to a major new
survey[1] from Saudi-based cultural institute,Ithra
2021-09-07 08:01
5814
JW Therapeutics Announces NMPA Approval of Relmacabtagene Autoleucel Injection in China
* The first CAR-T product independently developed in China and approved as a Category 1 biologics product, and the sixth approved CAR-T product globally * Currently the only approved CAR-T product that has been simultaneously included in the National Significant New Drug Development Program, g...
2021-09-06 19:03
6160
GenScript ProBio Enters into Agreement with SYNIMMUNE for Manufacturing of their Innovative Antibody Drug
NANJING, China, Sept. 6, 2021 /PRNewswire/ -- GenScript ProBio is delighted to announce the signing of a manufacturing service agreement for Synimmune's innovative FLYSYN antibody project for clinical Phase II production. FLYSYN is a fms-like tyrosine kinase 3 (FLT3) specific antibody for the ...
2021-09-06 16:00
3672
Inspiration Capital Partners announces Investment in Beijing Loving Care International Pet Medical Center
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Inspiration Capital Partners ("ICP") today announced an investment in Beijing Loving Care International Pet Medical Center ("Loving Care"). Founded in 2013, Loving Care is a leading premium specialty pet healthcare chain, focusing on providing high quality...
2021-09-06 15:32
4108
Peijia Medical Engages Professor Saibal Kar as Exclusive Consultant
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- Peijia Medical Limited (HKEX: 9996) is pleased to announceSaibal Kar MD, FACC, FSCAI, board-certified interventional cardiologist has agreed to become our exclusive consultant in China to advise the research and development of our Mitral Transcatheter E...
2021-09-06 13:44
4609
Kintor Pharma Included in Hong Kong Stock Connect Program
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma," HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today that the company's stock has been included in the Hong Kong Stock Conn...
2021-09-06 11:30
4880
CStone Pharmaceuticals Included in the Hong Kong Stock Connect
SUZHOU, China, Sept. 6, 2021 /PRNewswire/ -- CStone Pharmaceuticals (HKEX: 2616, "CStone" or the "Company"), a leading biopharmaceutical company focused on researching, developing and commercializing innovative immuno-oncology therapies and precision medicines, announced that the Company has been...
2021-09-06 11:30
5138
Lunit AI Receives HSA Approval, Now Commercially Available in Singapore
* Lunit AI products for analyzing chest X-ray and mammograms now approved to support medical professionals ofSingapore, by detecting suspicious lesions with 96-99% accuracy * Applied in one of Singapore's leading healthcare center, with positive feedback from the users SEOUL, South Korea, Sep...
2021-09-06 09:30
2604
GeneQuantum and BrighGene sign agreement for development of antibody immune agonist conjugates
SUZHOU, China, Sept. 5, 2021 /PRNewswire/ -- GeneQuantum Healthcare (Suzhou) Co.,Ltd. (hereinafter referred to as "GeneQuantum") and BrighGene Biomedical (Suzhou) Co.,Ltd. (hereinafter referred to as "BrighGene ") signed a co-development agreement for antibody immune agonist conjugate (AIAC), GQ1...
2021-09-06 09:00
2020
Gannex Announces Clinical Trial Application of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis Accepted by China NMPA
SHANGHAI, Sept. 6, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the clinical trial application of ASC42 to treat patients with primary biliary cholangitis (PBC) has been accepted for review by China National Medical ...
2021-09-06 08:30
4223
AffaMed Therapeutics Enters into Strategic Partnership Agreement with Beijing Tiantan Hospital and Infinite Brain Technologies to Promote Digital Therapy in Neurological Diseases
BEIJING, Sept. 5, 2021 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biopharmaceutical company dedicated to addressing critical unmet medical needs in ophthalmic, neurological and psychiatric disorders, announced during the recent "China International Trade in Servi...
2021-09-06 08:00
1824
WuXi AppTec Receives AA ESG Rating from MSCI
SHANGHAI, Sept. 5, 2021 /PRNewswire/ -- WuXi AppTec ("the Company") is pleased to announce that Morgan Stanley Capital International ("MSCI") has upgraded its MSCI ESG Rating to AA. The Company also received outstanding scores in the areas of "corporate governance" and "product safety and quality...
2021-09-06 08:00
3729
The National Medical Products Administration (NMPA) issues product license for Abiraterone acetate 250 mg, Bioequivalance study conducted in India by Accutest Research Laboratories (I) Pvt. Ltd., one of the Top Indian CRO
BEIJING and MUMBAI, India, Sept. 6, 2021 /PRNewswire/ -- National Medical
Products Administration
2021-09-06 08:00
2866
Avidity Science Announces Agreement to Divest Lab Products & Harford Systems
WATERFORD, Wis., Sept. 4, 2021 /PRNewswire/ -- Avidity Science, a worldwide leader in life science research tools, today announces it has sold its subsidiaries of Lab Products, LLC. and Harford Systems, LLC. to Gen Cap America, Inc. ("Gen Cap"), a private equity firm focused on lower middle marke...
2021-09-04 00:00
5661
Week's Top Stories
Most Reposted
Visa Expands Support for its Clients and the Industry as Organisations Navigate New AI Era of Cybersecurity
[Picked up by 315 media titles]
2026-08-28 09:01Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
[Picked up by 313 media titles]
2026-08-27 10:25
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
[Picked up by 304 media titles]
2026-08-24 10:00
Henox and Nexusguard Announce Strategic Alliance at BATIC 2026 to Power and Protect the Next Generation of Digital Infrastructure
[Picked up by 297 media titles]
2026-08-25 10:00OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
[Picked up by 291 media titles]
2026-08-24 15:42
Most Read
AIMX Singapore 2026 Accelerates AI Deployment Through Catalysing Industry Innovation and Advancing Global Collaborations
2026-08-24 10:00
14224
OGA 2026 Positions Kuala Lumpur as the Regional Marketplace for Southeast Asia's Energy Growth
2026-08-24 15:42
14027
Rewarding Meetings Begin At Hyatt Regency Kuala Lumpur At KL Midtown
2026-08-25 07:00
12070
Klook and Mastercard collaborate to enhance travelers' experiences across Asia Pacific
2026-08-27 10:25
7571